Looming federal patient privacy regulations and approaching Health Insurance Portability and Accountability Act of 1996 compliance deadlines are the biggest concerns of healthcare providers, according to preliminary results of a survey released at the
Looming federal patient privacy regulations and approaching Health Insurance Portability and Accountability Act of 1996 compliance deadlines are the biggest concerns of healthcare providers, according to preliminary results of a survey released at the February annual conference of the Healthcare Information and Management Systems Society (HIMSS). Some 61% of this year's respondents rated the need to upgrade security on IT systems to meet HIPPAA requirements as their highest IT priority in the coming year, up from 55% last year. Some 54% believe HIPAA will be the top priority next year as well, up from 51% in 2000. Losing ground was the deployment of Internet technology-last year's number one IT concern-which was cited by 46% of this year's participants, compared with 63% in 2000. Complete and final results of the survey will be available on the HIMSS Web site (www.himss.org) in early March.
2/28/01, Issue # 1504, page 2.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.